<DOC>
	<DOC>NCT01670552</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety of an association with one anti-inflammatory and one gastroprotective agent compared to the one anti-inflammatory and one gastroprotective agent in patients with acute or chronic osteoarticular inflammation.</brief_summary>
	<brief_title>Evaluation of Two Therapies for the Treatment of Osteoarticular Inflammation in Dyspeptic Patients</brief_title>
	<detailed_description>- Double-blind,randomized, multicenter - Experiment duration: 14 days - 03 visits - Evaluate the safety of an association with one anti-inflammatory and one gastroprotective compared to association with one anti-inflammatory and one gastroprotective agent in patients with acute or chronic osteoarticular inflammation - Adverse events evaluation</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Dyspepsia</mesh_term>
	<mesh_term>Pantoprazole</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<mesh_term>Nimesulide</mesh_term>
	<criteria>Adults male or female aged â‰¥ 18 years old; Comply with all the purposes and procedures of the study by signing and dating the Informed Consent. Acute or chronic osteoarticular injury in need of of antiinflammatory for a period of 14 days. Pregnant women, or women in childbearing age who are not in use effective contraception or intending to become pregnant during the study period History of peptic ulcer or gastric surgery; Use of Nonsteroidal antiinflammatory (NSAIDs), aspirin, proton pump inhibitor (PPIs), H2 blocker and antacid in the past 7 days; Contraindication to the use of NSAIDs or PPIs; Renal or hepatic impairment;</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>